{"id":"W4404974723","doi":"10.1038/s41416-024-02918-x","title":"Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Clusterin; Sorafenib; Renal cell carcinoma; Cancer research; Carcinoma; Medicine; Oncology; Internal medicine; Apoptosis; Biology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00227831,0.00152609,0.001331705,0.0008732787,0.001126917,0.002233332,0.001644437,0.007419075,0.005778211],"category_scores_gemma":[0.006253639,0.0006660104,0.001396296,0.000425968,0.001242414,0.001195421,0.0005458957,0.009576159,0.003874114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00153035,"about_ca_system_score_gemma":0.001146304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007897489,"about_ca_topic_score_gemma":0.001380214,"domain_scores_codex":[0.9985327,0.000221589,0.0001639949,0.0002408365,0.0007094864,0.0001314278],"domain_scores_gemma":[0.9938187,0.001990037,0.0005418761,0.0001640597,0.002496224,0.0009890909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002028814,0.00002761901,0.00008927031,0.0002618031,0.00002763875,0.0003841453,0.00001629948,0.00003970563,0.0006647822,0.0003097882,0.9891931,0.008783],"study_design_scores_gemma":[0.000145833,0.0001616152,0.0008306146,0.0001505513,0.00009767884,0.0009689481,0.00004441809,0.0003038736,0.001284249,0.0006283427,0.9953571,0.00002682751],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0006460522,0.00500362,0.0004416631,0.06320878,0.928497,0.00003858013,0.0001292971,0.0001159397,0.001919162],"genre_scores_gemma":[0.003895545,0.003894521,0.0002796199,0.03880379,0.9377159,0.00004091876,0.0000910583,0.00003687061,0.01524175],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.992581,"threshold_uncertainty_score":0.01933008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03053364576089337,"score_gpt":0.3381598795438008,"score_spread":0.3076262337829075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}